BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 36360276)

  • 21. Correlation between Genomic Variants and Worldwide Epidemiology of Prostate Cancer.
    Vieira GM; Gellen LPA; da Veiga Borges Leal DF; Pastana LF; Vinagre LWMS; Aquino VT; Fernandes MR; de Assumpção PP; Burbano RMR; Dos Santos SEB; Dos Santos NPC
    Genes (Basel); 2022 Jun; 13(6):. PubMed ID: 35741800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Individual and cumulative effect of prostate cancer risk-associated variants on clinicopathologic variables in 5,895 prostate cancer patients.
    Kader AK; Sun J; Isaacs SD; Wiley KE; Yan G; Kim ST; Fedor H; DeMarzo AM; Epstein JI; Walsh PC; Partin AW; Trock B; Zheng SL; Xu J; Isaacs W
    Prostate; 2009 Aug; 69(11):1195-205. PubMed ID: 19434657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polygenic risk score in prostate cancer.
    Oh JJ; Hong SK
    Curr Opin Urol; 2022 Sep; 32(5):466-471. PubMed ID: 35855560
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Testing the generalizability of ancestry-specific polygenic risk scores to predict prostate cancer in sub-Saharan Africa.
    Kim MS; Naidoo D; Hazra U; Quiver MH; Chen WC; Simonti CN; Kachambwa P; Harlemon M; Agalliu I; Baichoo S; Fernandez P; Hsing AW; Jalloh M; Gueye SM; Niang L; Diop H; Ndoye M; Snyper NY; Adusei B; Mensah JE; Abrahams AOD; Biritwum R; Adjei AA; Adebiyi AO; Shittu O; Ogunbiyi O; Adebayo S; Aisuodionoe-Shadrach OI; Nwegbu MM; Ajibola HO; Oluwole OP; Jamda MA; Singh E; Pentz A; Joffe M; Darst BF; Conti DV; Haiman CA; Spies PV; van der Merwe A; Rohan TE; Jacobson J; Neugut AI; McBride J; Andrews C; Petersen LN; Rebbeck TR; Lachance J
    Genome Biol; 2022 Sep; 23(1):194. PubMed ID: 36100952
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polymorphisms in oxidative stress pathway genes and prostate cancer risk.
    Zhang Z; Jiang D; Wang C; Garzotto M; Kopp R; Wilmot B; Thuillier P; Dang A; Palma A; Farris PE; Shannon J
    Cancer Causes Control; 2019 Dec; 30(12):1365-1375. PubMed ID: 31667711
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrative functional genomics identifies an enhancer looping to the SOX9 gene disrupted by the 17q24.3 prostate cancer risk locus.
    Zhang X; Cowper-Sal lari R; Bailey SD; Moore JH; Lupien M
    Genome Res; 2012 Aug; 22(8):1437-46. PubMed ID: 22665440
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic factors influencing prostate cancer risk in Norwegian men.
    Chen H; Ewing CM; Zheng S; Grindedaal EM; Cooney KA; Wiley K; Djurovic S; Andreassen OA; Axcrona K; Mills IG; Xu J; Maehle L; Fosså SD; Isaacs WB
    Prostate; 2018 Feb; 78(3):186-192. PubMed ID: 29181843
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A genome-wide survey over the ChIP-on-chip identified androgen receptor-binding genomic regions identifies a novel prostate cancer susceptibility locus at 12q13.13.
    Feng J; Sun J; Kim ST; Lu Y; Wang Z; Zhang Z; Gronberg H; Isaacs WB; Zheng SL; Xu J
    Cancer Epidemiol Biomarkers Prev; 2011 Nov; 20(11):2396-403. PubMed ID: 21960693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of MMP-3 and TIMP-3 gene polymorphisms on prostate cancer susceptibility in North Indian cohort.
    Srivastava P; Kapoor R; Mittal RD
    Gene; 2013 Nov; 530(2):273-7. PubMed ID: 23872201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional annotation of risk loci identified through genome-wide association studies for prostate cancer.
    Lu Y; Zhang Z; Yu H; Zheng SL; Isaacs WB; Xu J; Sun J
    Prostate; 2011 Jun; 71(9):955-63. PubMed ID: 21541972
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of genetic polymorphisms in the interleukin-10 promoter with risk of prostate cancer in Chinese.
    Liu J; Song B; Bai X; Liu W; Li Z; Wang J; Zheng Y; Wang Z
    BMC Cancer; 2010 Aug; 10():456. PubMed ID: 20735825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population.
    Takata R; Takahashi A; Fujita M; Momozawa Y; Saunders EJ; Yamada H; Maejima K; Nakano K; Nishida Y; Hishida A; Matsuo K; Wakai K; Yamaji T; Sawada N; Iwasaki M; Tsugane S; Sasaki M; Shimizu A; Tanno K; Minegishi N; Suzuki K; Matsuda K; Kubo M; Inazawa J; Egawa S; Haiman CA; Ogawa O; Obara W; Kamatani Y; Akamatsu S; Nakagawa H
    Nat Commun; 2019 Sep; 10(1):4422. PubMed ID: 31562322
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of THADA, FOXP4, GPRC6A/RFX6 genes and 8q24 risk alleles with prostate cancer in Northern Chinese men.
    Li XH; Xu Y; Yang K; Shi JJ; Zhang X; Yang F; Yuan H; Zhu X; Zhang YH; Wang JY; Yang Z
    J BUON; 2015; 20(5):1223-8. PubMed ID: 26537068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of Toll-like receptor (TLR) 2, 3 and 9 genes polymorphism with prostate cancer risk in North Indian population.
    Mandal RK; George GP; Mittal RD
    Mol Biol Rep; 2012 Jul; 39(7):7263-9. PubMed ID: 22311043
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanistic insights into genetic susceptibility to prostate cancer.
    Tian P; Zhong M; Wei GH
    Cancer Lett; 2021 Dec; 522():155-163. PubMed ID: 34560228
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification and validation of regulatory SNPs that modulate transcription factor chromatin binding and gene expression in prostate cancer.
    Jin HJ; Jung S; DebRoy AR; Davuluri RV
    Oncotarget; 2016 Aug; 7(34):54616-54626. PubMed ID: 27409348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of Risk Allele Frequencies of Psoriasis-Associated Single-Nucleotide Polymorphisms in Different Population Groups.
    Lee D; Koo T; Park J; Shin HT
    Ann Dermatol; 2023 Feb; 35(1):32-37. PubMed ID: 36750456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of association between common variants at 17q12 and prostate cancer risk-evidence from Serbian population and meta--analysis.
    Nikolić ZZ; Branković AS; Savić-Pavićević DL; Preković SM; Vukotić VD; Cerović SJ; Filipović NN; Tomović SM; Romac SP; Brajušković GN
    Clin Transl Sci; 2014 Aug; 7(4):307-13. PubMed ID: 24422606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polymorphisms of Genes Involved in Glucose and Energy Metabolic Pathways and Prostate Cancer: Interplay with Metformin.
    Murtola TJ; Wahlfors T; Haring A; Taari K; Stenman UH; Tammela TL; ; Schleutker J; Auvinen A
    Eur Urol; 2015 Dec; 68(6):1089-97. PubMed ID: 25819720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of genetic polymorphisms in vitamin D receptor gene and susceptibility to sporadic prostate cancer.
    Onen IH; Ekmekci A; Eroglu M; Konac E; Yesil S; Biri H
    Exp Biol Med (Maywood); 2008 Dec; 233(12):1608-14. PubMed ID: 18849534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.